Resources

Ten Mistakes to Avoid when Searching Gene Sequences

Avoid the costly pitfalls of inaccurate, irrelevant, and untimely search results - what you need to consider before your next search.
Learn More»

The value of a cost-effective informatics platform that enables rapid and relevant search of the vast universe of sequences and their patents with regard to commercialization of new drugs cannot be understated. This is particularly true in the fast-paced R&D area of infectious disease research. We selected GenomeQuest™ for its ability to instantly locate sequence data and display it in an intuitive and easily manipulated format.
Director of Research (Anti-Infectives) and Manager, Intellectual Property

Falco-Archer and GenomeQuest

Comprehensive and Fast sequence search yields customer satisfaction and confidence, which helps separate Falco-Archer from the field.

Situation and Challenge

Falco-Archer provides strategic Intellectual Property management services to companies, law firms, investment firms, and philanthropies worldwide. Their IP services assist organizations create more value and protect competitive positions. Strengthened Intellectual Property portfolios result in enhanced value to partners, investors, and acquirers and help organizations achieve their core missions and strategic objectives.

Prior to adopting GenomeQuest from GenomeQuest, Greg Galloway, President of Falco-Archer, and his team relied on multiple data sources that produced stacks of mostly-irrelevant results. GenomeQuest relieved this time-consuming bottleneck, which allows Falco-Archer to produce analyses fast. By using GenomeQuest to perform sequence searches, Greg and his team has more time to provide strategic value to their customers.

The GenomeQuest™ Solution Tailored to Falco-Archer

Most of the key success criteria for Falco-Archer hinged on GenomeQuest's quality of content, powerful search algorithms, and ease-of-use. Working with Greg Galloway GenomeQuest proposed the pay-per-use GenomeQuest solution. Although crucial to their business, sequence searching is required sporadically. GenomeQuest's pay-per-use model provides Falco-Archer with greater flexibility.

Since adopting GQ, Greg has been pleased with the product's superior reports, ease-of-use and performance. "GenomeQuest saves us a lot of time and allows us to expand service to our customers in other ways", says Greg. "It's a nice sharp tool. When you need it, it just works. I am completely confident with the results."

Greg concluded by saying, "I advise my clients to integrate IP into their research decisions at an early stage in their company's design and development process — before heavy investments are made." With GenomeQuest this is now possible.